Skip to main content
. 2005 Aug 14;11(30):4735–4739. doi: 10.3748/wjg.v11.i30.4735

Figure 3.

Figure 3

Immunocytochemistry of rHSC-99 ×100. A: Positive of PPARγ in 10 µmol/L rosiglitazone group; B: positive of α-SMA in control group; C: weak positive of α-SMA in 10 µmol/L rosiglitazone group.